CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: figitumumab|OTHER: imaging biomarker analysis|OTHER: laboratory biomarker analysis|OTHER: pharmacological study|PROCEDURE: conventional surgery|PROCEDURE: magnetic resonance spectroscopic imaging|PROCEDURE: neoadjuvant therapy
Sponsor: Pfizer
Collaborators: National Cancer Institute (NCI)